All treatments
Treatment
Etrasimod Arginine Blue clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingHuman Pharmacology (Phase I)- Other
C5041050 - A Phase 1, Open-Label, Single Dose, Fixed-Sequence Crossover Sub Study to Determine the Pharmacokinetics Using Tasso Device and Safety and Tolerability Using Wearable Monitoring Devices Following Single Oral Doses of Etrasimod 2 mg IR Tablets in Healthy Adult Participants in a Hybrid Decentralized Clinical Trial Design
This study is looking into a new medicine called etrasimod. It aims to understand how etrasimod works in the body for conditions like ulcerative colitis, alopecia areata, eczema, and a specific gut issue. It's a very early stage study, done partly from home.
For: immune-mediated inflammatory disorders, including ulcerative colitis, alopecia areata, atopic dermatitis, and eosinophilic esophagitisBelgium - RecruitingHuman Pharmacology (Phase I)- Other
C5041053 - A PHASE 1 MULTIPLE-DOSE, OPEN-LABEL PHARMACOKINETIC STUDY OF ETRASIMOD IN HEALTHY LACTATING WOMEN
This study looks at etrasimod, a medicine used for bowel conditions like ulcerative colitis. Researchers want to find out how much of the medicine passes into breast milk. Healthy breastfeeding women aged 18 and older will take the medicine and provide milk and blood samples to measure drug levels.
For: Ulcerative Colitis and immune-mediated inflammatory disordersBelgium